Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/15/2013 | US8354570 Disease resistant plants |
01/15/2013 | US8354569 Plant acyltransferases specific for long-chained, multiply unsaturated fatty acids |
01/15/2013 | US8354522 Immunostimulatory oligoribonucleotides |
01/15/2013 | US8354521 Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma |
01/15/2013 | US8354519 Corn event MIR604 |
01/15/2013 | US8354518 HCV replicons containing NS5B from genotype 2B |
01/15/2013 | US8354517 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from Alicyclobacillus acidocaldarius and related organisms, methods |
01/15/2013 | US8354516 Polypeptide producing cells |
01/15/2013 | US8354513 Polynucleotides encoding BSL2vcvc-lg |
01/15/2013 | US8354510 Mutant protein |
01/15/2013 | US8354504 Chimeric isoprenoid synthases and uses thereof |
01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
01/15/2013 | US8354391 Anti-WSSV and/or TSV nucleic acid drug |
01/15/2013 | US8354390 Compositions and methods for inhibiting expression of a gene from the ebola virus |
01/15/2013 | US8354389 miRNA-regulated differentiation-dependent self-deleting cassette |
01/15/2013 | US8354388 Inhibitors of MRP4 for the treatment of vascular disorders |
01/15/2013 | US8354387 Methods and compositions for delivering siRNA into mammalian cells |
01/15/2013 | US8354386 Pharmaceutical composition for treating malignant tumors containing human p31 genes |
01/15/2013 | US8354385 Modulation of TRPV expression levels |
01/15/2013 | US8354384 Anti-aging micrornas |
01/15/2013 | US8354277 Isolated primate embryonic cells derived from extended blastocysts |
01/15/2013 | US8354273 Isoforms of human somatostatin receptor type 5 |
01/15/2013 | US8354272 Zinc-regulated prokaryotic expression cassettes |
01/15/2013 | US8354268 Protein glycosylation modification in methylotrophic yeast |
01/15/2013 | US8354266 Method for producing extracellular multi-enzyme complexes in host cells |
01/15/2013 | US8354264 Polynucleotides encoding novel PCSK9 variants |
01/15/2013 | US8354263 Family 44 xyloglucanases |
01/15/2013 | US8354251 Transactivation system for mammalian cells |
01/15/2013 | US8354250 Neurotransmitter sensors and methods of using the same |
01/15/2013 | US8354248 Promoter-encoding DNA fragment, recombinant vector, recombiant transformant, and uses thereof |
01/15/2013 | US8354226 Assay for detection of human parvovirus B19 nucleic acid |
01/15/2013 | US8354113 Gene expressing a bifidobacterium surface-presented fusion protein |
01/15/2013 | CA2631587C Chemokine-mucin fusions linked to glycosylphosphatidylinositol (gpi)-anchors in tissue regeneration and as tumour immune adjuvants |
01/15/2013 | CA2583375C Regulation of oncogenes by micrornas |
01/15/2013 | CA2560946C Compositions for use in identification of viral hemorrhagic fever viruses |
01/15/2013 | CA2550583C Modified cea /b7 vector |
01/15/2013 | CA2550507C Method for producing yellow flower by controlling flavonoid synthetic pathway |
01/15/2013 | CA2529828C Factor vii or viia gla domain variants |
01/15/2013 | CA2478614C Electromanipulation device and method |
01/15/2013 | CA2475929C Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
01/15/2013 | CA2466156C Ehrlichia disulfide bond formation proteins and uses thereof |
01/15/2013 | CA2461710C Incapacitated whole-cell immunogenic bacterial compositions |
01/15/2013 | CA2460269C Alphavirus replicon vector systems |
01/15/2013 | CA2451864C Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
01/15/2013 | CA2443323C Nucleic acid vaccines for prevention of flavivirus infection |
01/15/2013 | CA2409031C Insecticidal secreted proteins of brevibacillus laterosporus |
01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
01/15/2013 | CA2400842C Novel compounds |
01/15/2013 | CA2322449C Biosynthetic genes for spinosyn insecticide production |
01/14/2013 | CA2783652A1 Compositions, methods and kits to detect dicer gene mutations |
01/14/2013 | CA2782916A1 Host cells and methods for producing fatty acid |
01/10/2013 | WO2013006861A1 Sorghum grain shattering gene and uses thereof in altering seed dispersal |
01/10/2013 | WO2013006815A1 Methods and compositions to modulate antiviral and immune activity responses |
01/10/2013 | WO2013006756A2 Alpha amylase variants and polynucleotides encoding same |
01/10/2013 | WO2013006722A1 Hcv genotype 3 replicons |
01/10/2013 | WO2013006721A1 Hcv genotype 4 replicons |
01/10/2013 | WO2013006502A1 Method for extracting rna from fixed embedded tissue |
01/10/2013 | WO2013006472A1 Methods and compositions for selective regulation of protein expression |
01/10/2013 | WO2013006361A1 Modulation of low carbon dioxide inducible proteins (lci) for increased biomass production and photosynthesis |
01/10/2013 | WO2013006345A2 Plants with improved agronomic traits |
01/10/2013 | WO2013006263A2 Constitutively active aba receptor mutants |
01/10/2013 | WO2013006142A1 A novel process and reagent for rapid genetic alterations in eukaryotic cells |
01/10/2013 | WO2013006069A1 Peptide with the enzymatic activity of a dicer-like protein, a method for preparing short rna molecules, and use thereof |
01/10/2013 | WO2013006058A1 Use of jaz5a for improving drought-resistance in a plant |
01/10/2013 | WO2013005723A1 Method for evaluating redox activity of nucleic acid molecule, and nucleic acid molecule having redox activity |
01/10/2013 | WO2013005649A1 Anti-human ccr6 antibody |
01/10/2013 | WO2013005603A1 Agent for prevention and/or treatment of allergic inflammation in conjunctiva |
01/10/2013 | WO2013005595A1 Novel method for producing ethanol |
01/10/2013 | WO2013005403A1 Method for determination of onset sensitivity or onset resistance to heat stroke |
01/10/2013 | WO2013005211A2 Boron complexing plant materials and uses thereof cross-reference to related applications |
01/10/2013 | WO2013005152A1 Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
01/10/2013 | WO2013005042A2 Anti-viral therapy |
01/10/2013 | WO2013004906A1 Improving the production of foreign proteins |
01/10/2013 | WO2013004848A1 Caveolin-1 in tumor-associated fibroblasts as biomarker for tumor progression |
01/10/2013 | WO2013004817A1 Genetically modified phage and use thereof |
01/10/2013 | WO2013004716A1 Peptide beads |
01/10/2013 | WO2013004710A2 Reagent usable for the isolation and/or purification of nucleic acids |
01/10/2013 | WO2013004668A1 Root preferred promoters derived from rice and methods of use |
01/10/2013 | WO2013004644A1 Microfluidic device with integrated sensors for cultivation of cells |
01/10/2013 | WO2013004396A2 Adeno-parvovirus chimera with enhanced oncolytical potential |
01/10/2013 | WO2013004281A1 Nucleotide sequences mutated by insertion that encode a truncated oleate desaturase protein, proteins, methods and uses |
01/10/2013 | WO2013004280A1 Isolated mutated nucleotide sequences that encode a modified oleate destaurase sunflower protein, modified protein, methods and uses |
01/10/2013 | WO2013004135A1 Preparation method for inductive pluripotent stem cells and culture medium for preparing inductive pluripotent stem cells |
01/10/2013 | WO2013004076A1 Agr2 blocking antibody and use thereof |
01/10/2013 | WO2013003987A1 Tumor-targeted tumor necrosis factor-related apoptosis ligand variant and use thereof |
01/10/2013 | WO2013003983A1 Swine myostatin locus and use thereof |
01/10/2013 | WO2013003904A1 Recombinant low virulence bovine herpesvirus 1 (bohv-1) vaccine vectors |
01/10/2013 | WO2012159006A8 Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof |
01/10/2013 | WO2012158818A3 Multi-specific fab fusion proteins and methods of use |
01/10/2013 | WO2012158631A3 Photothermal substrates for selective transfection of cells |
01/10/2013 | WO2012158603A3 Pooled adapter strategy for reducing bias in small rna characterization |
01/10/2013 | WO2012156744A3 Gel beads in microfluidic droplets |
01/10/2013 | WO2012151575A3 A method of controlling coagulation |
01/10/2013 | WO2012145692A3 Diffusion-based method for obtaining volatile hydrocarbons produced by photosynthetic microorganisms in two-phase bioreactors |
01/10/2013 | WO2012142171A3 Improved cellulase variants |
01/10/2013 | WO2012141554A3 Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor |
01/10/2013 | WO2012141547A3 Enhanced-activity modified beta-glucosidase and a manufacturing method for bioethanol using same |
01/10/2013 | WO2012138102A3 Dlk1-specific human antibodies and pharmaceutical composition containing same |
01/10/2013 | WO2012138100A3 Activin receptor type ii b inhibitors comprising dlk1 extracellular water-soluble domain |
01/10/2013 | WO2012134241A3 Zinc finger nuclease targeting the cmah gene, and a use therefor |